The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, and the majority of NSCLC patients are diagnosed at the advanced stage. Chemotherapy is still the main treatment at present, and the overall prognosis is poor. In recent years, immunotherapy has developed rapidly....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biomed Res Int
Päätekijät: Nan, Zhang, Guoqing, Wang, Xiaoxu, Yu, Yin, Mi, Xin, He, Xue, Li, Rong, Wang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2021
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984892/
https://ncbi.nlm.nih.gov/pubmed/33791360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/1780860
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia